Guided Therapeutics (GTHP) Leases (2019 - 2025)
Guided Therapeutics' Leases history spans 7 years, with the latest figure at $69000.0 for Q3 2025.
- For Q3 2025, Leases fell 57.93% year-over-year to $69000.0; the TTM value through Sep 2025 reached $69000.0, down 57.93%, while the annual FY2024 figure was $141000.0, 37.89% down from the prior year.
- Leases for Q3 2025 was $69000.0 at Guided Therapeutics, down from $94000.0 in the prior quarter.
- Across five years, Leases topped out at $426000.0 in Q1 2021 and bottomed at $69000.0 in Q3 2025.
- The 5-year median for Leases is $266000.0 (2023), against an average of $258368.4.
- The largest annual shift saw Leases surged 536.07% in 2021 before it tumbled 57.93% in 2025.
- A 5-year view of Leases shows it stood at $372000.0 in 2021, then decreased by 18.55% to $303000.0 in 2022, then fell by 25.08% to $227000.0 in 2023, then tumbled by 37.89% to $141000.0 in 2024, then tumbled by 51.06% to $69000.0 in 2025.
- Per Business Quant, the three most recent readings for GTHP's Leases are $69000.0 (Q3 2025), $94000.0 (Q2 2025), and $118000.0 (Q1 2025).